Trinity Biotech (TRIB) Total Liabilities (2009 - 2025)

Trinity Biotech's Total Liabilities history runs 17 years deep, the most recent figure standing at $177.1 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 27.93% year-over-year to $177.1 million; the TTM figure through Dec 2025 stood at $177.1 million (up 27.93% YoY), while the FY2025 annual figure was $177.1 million, up 27.93% from the prior year.
• Total Liabilities came in at $177.1 million for Q4 2025 at Trinity Biotech, up from $149.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $177.1 million in Q4 2025 to a low of $81.1 million in Q3 2023.
• A 5-year average of $114.6 million and a median of $116.2 million in 2021 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities dropped 27.07% in 2022 and soared 66.06% in 2024, its largest moves.
• Trinity Biotech's Total Liabilities stood at $119.2 million in 2021, then declined by 20.92% to $94.3 million in 2022, then retreated by 11.56% to $83.4 million in 2023, then jumped by 66.06% to $138.5 million in 2024, then rose by 27.93% to $177.1 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $177.1 million, $149.2 million, and $138.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison